DE602006014120D1 - Kolloidale metallkonjugate - Google Patents
Kolloidale metallkonjugateInfo
- Publication number
- DE602006014120D1 DE602006014120D1 DE602006014120T DE602006014120T DE602006014120D1 DE 602006014120 D1 DE602006014120 D1 DE 602006014120D1 DE 602006014120 T DE602006014120 T DE 602006014120T DE 602006014120 T DE602006014120 T DE 602006014120T DE 602006014120 D1 DE602006014120 D1 DE 602006014120D1
- Authority
- DE
- Germany
- Prior art keywords
- colloidal metal
- metal conjugates
- conjugates
- quantitative
- samples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
- A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Ceramic Engineering (AREA)
- Nanotechnology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Chemically Coating (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66585105P | 2005-03-29 | 2005-03-29 | |
PCT/US2006/011323 WO2006105111A2 (en) | 2005-03-29 | 2006-03-28 | Colloidal metal conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006014120D1 true DE602006014120D1 (de) | 2010-06-17 |
Family
ID=37054025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006014120T Active DE602006014120D1 (de) | 2005-03-29 | 2006-03-28 | Kolloidale metallkonjugate |
Country Status (6)
Country | Link |
---|---|
US (1) | US8232045B2 (de) |
EP (1) | EP1869468B1 (de) |
CN (1) | CN101151532B (de) |
AT (1) | ATE467128T1 (de) |
DE (1) | DE602006014120D1 (de) |
WO (1) | WO2006105111A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8777875B2 (en) * | 2008-07-23 | 2014-07-15 | Otismed Corporation | System and method for manufacturing arthroplasty jigs having improved mating accuracy |
US8039272B2 (en) * | 2009-04-01 | 2011-10-18 | Nova Biomedical | Rapid quantification assay involving concentrated and ligand-coated gold colloid |
CA2781110C (en) * | 2009-11-17 | 2018-07-31 | Abaxis, Inc. | Peptides and methods for the detection of lyme disease antibodies |
KR101787791B1 (ko) | 2010-04-14 | 2017-10-19 | 니토 보세키 가부시기가이샤 | 시료 중의 분석 대상 물질을 측정하기 위한 검사 기구 및 그것을 사용한 분석 대상 물질의 측정 방법 |
US8758772B2 (en) | 2011-11-04 | 2014-06-24 | Abaxis, Inc. | Peptides and methods for the detection of lyme disease antibodies |
CN103901195B (zh) * | 2014-03-27 | 2016-01-20 | 云南省烟草农业科学研究院 | 一种检测烟草花叶病毒的胶体金免疫层析试纸及其制备方法 |
CN111821316A (zh) * | 2019-04-19 | 2020-10-27 | 北京大学 | 用于免疫增强的锰组合物 |
CN112691120B (zh) * | 2019-10-23 | 2022-03-29 | 北京大学 | 二价锰在制备免疫增强药物或抗肿瘤药物中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7807532A (nl) * | 1978-07-13 | 1980-01-15 | Akzo Nv | Metaal-immunotest. |
US5120643A (en) * | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
US4859612A (en) * | 1987-10-07 | 1989-08-22 | Hygeia Sciences, Inc. | Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite |
AU2684488A (en) * | 1988-06-27 | 1990-01-04 | Carter-Wallace, Inc. | Test device and method for colored particle immunoassay |
US5252496A (en) * | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
-
2006
- 2006-03-28 DE DE602006014120T patent/DE602006014120D1/de active Active
- 2006-03-28 CN CN200680010431XA patent/CN101151532B/zh active Active
- 2006-03-28 EP EP06739848A patent/EP1869468B1/de active Active
- 2006-03-28 WO PCT/US2006/011323 patent/WO2006105111A2/en active Application Filing
- 2006-03-28 AT AT06739848T patent/ATE467128T1/de not_active IP Right Cessation
- 2006-03-28 US US11/887,145 patent/US8232045B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US8232045B2 (en) | 2012-07-31 |
CN101151532A (zh) | 2008-03-26 |
WO2006105111A3 (en) | 2007-02-08 |
WO2006105111B1 (en) | 2007-03-29 |
US20100015636A1 (en) | 2010-01-21 |
ATE467128T1 (de) | 2010-05-15 |
CN101151532B (zh) | 2012-12-12 |
WO2006105111A2 (en) | 2006-10-05 |
EP1869468B1 (de) | 2010-05-05 |
EP1869468A2 (de) | 2007-12-26 |
EP1869468A4 (de) | 2009-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE467128T1 (de) | Kolloidale metallkonjugate | |
EA200970210A1 (ru) | Prlr-специфическое антитело и его применения | |
ATE519863T1 (de) | Nicht-fluoreszente energieübertragung | |
SV2007002227A (es) | Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina ref. 040000-0317637 | |
CY1117721T1 (el) | Κυτταρα προελευσης αμνιακου υγρου | |
HN2008001104A (es) | Compuestos para anticuerpos de dickpf-1 y70-4 | |
WO2006086208A3 (en) | 5-fluoro-uracil immunoassay | |
ATE306670T1 (de) | Elektrochemischer immunoassay mit kolloidalem metall | |
DK1864129T3 (da) | Doxurubicin-immunassay | |
MA30922B1 (fr) | Anticorps d'agonistes de trkb et leurs utilisations | |
NO20083397L (no) | Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse | |
ATE483825T1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
EP2302382A3 (de) | Docetaxel Konjugaten und Immunogenen zur Verwendung in einem Immunassay | |
CL2008001656A1 (es) | Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene. | |
NO20083147L (no) | Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse | |
BRPI0517647A (pt) | combinações de agonistas do receptor nicotìnico alfa 7 de acetilcolina | |
MX2007012486A (es) | Ensayos de investigacion sobre estilbazio. | |
NO20083593L (no) | Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse | |
MX2020006728A (es) | Metodos para medir analito y/o proteina en muestras biologicas. | |
SG171630A1 (en) | Protein detection reagents and methods with dyes and dextrins | |
WO2007149809A3 (en) | Tacrolimus standard and methods of using same | |
MX2009001341A (es) | Anticuerpos especificos de ephb3 y usos de los mismos. | |
DK1951395T3 (da) | Fremgangsmåde til kvantitativ bestemmelse af poloxamerer | |
WO2007051603A3 (en) | Kit comprising 2, 4- dichlorophenoxyacetic acd derivatives and antibodies for highly sensitive detection assays | |
MX2007013108A (es) | Reactivos que enlazan ccx-ckr2. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: ALERE SWITZERLAND GMBH, ZUG, CH |
|
8364 | No opposition during term of opposition |